Innovative Medical Technology

Neurotron, Incorporated

   Innovative Medical Technology

                 Established 1981

Neurometer® Clinical Oncology Applications

 Patient Care


 Press Releases






 Clinical Apps







Oncologists prescribe sNCT/CPT studies to assess the polyneuropathy of cancer and the neurotoxic side-effects of chemotherapeutic agents to assist in developing and modifying treatment plans/goals. A clinical presentation of sensory impairment which requires an objective evaluation for polyneuropathy with testing generally conducted at the great toe test site and a cephalic test site, bilaterally.  See the web page with related publications cited,  Selected Neurometer® CPT Research Publications Grouped by Topic and Specialty.


top of page      Previous page     Home



The entire contents of this web site are Copyright 1996-2010, Neurotron, Incorporated

Est. 1981, Baltimore, MD, USA.  All rights reserved, worldwide

rev 10/16/09